000902561 001__ 902561
000902561 005__ 20211130111101.0
000902561 0247_ $$2doi$$a10.1161/HYPERTENSIONAHA.121.18135
000902561 0247_ $$2Handle$$a2128/29062
000902561 0247_ $$2altmetric$$aaltmetric:115063667
000902561 0247_ $$2pmid$$apmid:34628935
000902561 0247_ $$2WOS$$aWOS:000707194400040
000902561 037__ $$aFZJ-2021-04360
000902561 082__ $$a610
000902561 1001_ $$0P:(DE-HGF)0$$aGronewold, J.$$b0$$eCorresponding author
000902561 245__ $$aAssociation of blood pressure, its treatment, and treatment efficacy with volume of white matter hyperintensities in the population-based 1000BRAINS Study
000902561 260__ $$aBaltimore, Md.$$bWilliams & Wilkins$$c2021
000902561 3367_ $$2DRIVER$$aarticle
000902561 3367_ $$2DataCite$$aOutput Types/Journal article
000902561 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1637322385_24320
000902561 3367_ $$2BibTeX$$aARTICLE
000902561 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000902561 3367_ $$00$$2EndNote$$aJournal Article
000902561 520__ $$aWhite matter hyperintensities (WMHs) of presumed vascular origin are a frequent finding in cerebral magnetic resonance imaging of older people. They are attributed to small vessel disease and involved in the pathogenesis of cognitive decline. Since vascular risk factors, especially arterial hypertension, predispose to small vessel disease, we analyzed the association of systolic blood pressure (SBP), diastolic blood pressure (DBP), and antihypertensive medications with WMH volume in 560 participants of the 1000BRAINS study, drawn from the population-based Heinz Nixdorf Recall study (65.2±7.5 years; 51.4% men). Further, we analyzed treatment efficacy using a classification of 6 BP treatment groups defined by antihypertensive medication and level of BP: (1) untreated BP <120/<80 mm Hg, (2) untreated SBP 120 to 139 or DBP 80 to 89 mm Hg, (3) untreated BP ≥140 or ≥90 mm Hg, (4) treated BP <120/<80 mm Hg, (5) treated SBP 120 to 139 or DBP 80 to 89 mm Hg, and (6) treated BP ≥140 or ≥90 mm Hg. Median WMH volume (Q1–Q3) was 4.6 (3.0–7.8) cm3; mean±SD of SBP and DBP was 128.6±17.4 and 76.1±9.8 mm Hg. In multivariable linear regression models, continuous SBP (β=0.63 cm3 per 10 mm Hg [95% CI, 0.32–0.94]), DBP (0.64 cm3 per 5 mmHg [95% CI, 0.37–0.91]), and antihypertensive treatment (1.23 cm3 [95% CI, 0.14–2.23]) were significantly associated with WMH volume. Regarding treatment efficacy, only participants with hypertension despite treatment (treated BP ≥140 or ≥90 mm Hg) had significantly increased WMH volume (4.24 cm3 [2.36–6.13]) compared with normotension without treatment (untreated BP <120/<80 mm Hg). Our results suggest that WMHs represent a marker of advanced hypertension pathology. Hence, early treatment should prevent WMHs.
000902561 536__ $$0G:(DE-HGF)POF4-5251$$a5251 - Multilevel Brain Organization and Variability (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000902561 588__ $$aDataset connected to DataCite
000902561 7001_ $$0P:(DE-HGF)0$$aJokisch, M.$$b1
000902561 7001_ $$0P:(DE-HGF)0$$aSchramm, S.$$b2
000902561 7001_ $$0P:(DE-Juel1)145386$$aJockwitz, Christiane$$b3
000902561 7001_ $$0P:(DE-Juel1)181023$$aMiller, Tatiana$$b4
000902561 7001_ $$0P:(DE-HGF)0$$aLehmann, N.$$b5
000902561 7001_ $$0P:(DE-HGF)0$$aMoebus, S.$$b6
000902561 7001_ $$0P:(DE-HGF)0$$aJöckel, K. H.$$b7
000902561 7001_ $$0P:(DE-Juel1)131675$$aCaspers, Svenja$$b8
000902561 7001_ $$0P:(DE-HGF)0$$aHermann, D. M.$$b9
000902561 773__ $$0PERI:(DE-600)2094210-2$$a10.1161/HYPERTENSIONAHA.121.18135$$n5$$p1490-1501$$tHypertension$$v78$$x0194-911X$$y2021
000902561 8564_ $$uhttps://juser.fz-juelich.de/record/902561/files/Gronewold_etal_Hypertension_2021.pdf$$yRestricted
000902561 8564_ $$uhttps://juser.fz-juelich.de/record/902561/files/Gronewold_etal_Hypertension_2021_Postprint.docx$$yPublished on 2021-10-11. Available in OpenAccess from 2022-04-11.$$zStatID:(DE-HGF)0510
000902561 909CO $$ooai:juser.fz-juelich.de:902561$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000902561 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145386$$aForschungszentrum Jülich$$b3$$kFZJ
000902561 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)181023$$aForschungszentrum Jülich$$b4$$kFZJ
000902561 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131675$$aForschungszentrum Jülich$$b8$$kFZJ
000902561 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5251$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000902561 9141_ $$y2021
000902561 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-30
000902561 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-30
000902561 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-01-30
000902561 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-30
000902561 915__ $$0StatID:(DE-HGF)0530$$2StatID$$aEmbargoed OpenAccess
000902561 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bHYPERTENSION : 2019$$d2021-01-30
000902561 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bHYPERTENSION : 2019$$d2021-01-30
000902561 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2021-01-30
000902561 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-30
000902561 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-30
000902561 915__ $$0StatID:(DE-HGF)0410$$2StatID$$aAllianz-Lizenz$$d2021-01-30$$wger
000902561 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-30
000902561 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2021-01-30
000902561 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2021-01-30$$wger
000902561 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-30
000902561 9201_ $$0I:(DE-Juel1)INM-1-20090406$$kINM-1$$lStrukturelle und funktionelle Organisation des Gehirns$$x0
000902561 980__ $$ajournal
000902561 980__ $$aVDB
000902561 980__ $$aUNRESTRICTED
000902561 980__ $$aI:(DE-Juel1)INM-1-20090406
000902561 9801_ $$aFullTexts